IL6 and neoplasm: Malignancies are thought to interact with platelets through numerous mechanisms including tumor expression of platelet receptors and tumor secretion of thrombin and tumor‐specific cytokines, specifically interleukin‐6 (IL‐6).6, 7, 20, 21